This is an update on sarcoidosis, focusing on etiology, diagnosis, and treatment. In the area
of etiopathogenesis, we now have a better understanding of the immune response that …

The investigatory technique of bronchoalveolar lavage (BAL) has become one of the most
valuable research tools for studying inflammatory mechanisms in a wide range of diseases …

Sarcoidosis is a granulomatous disease of unknown cause, occurs worldwide and has a
highly variable prevalence. The disease is typically dominant in the lungs, although it can …

Sarcoidosis may be affected by sex, race, and age. A Case Control Etiologic Study of
Sarcoidosis (ACCESS) enrolled 736 patients with sarcoidosis within 6 mo of diagnosis from …

Background: The clinical utility of bronchoalveolar lavage fluid (BAL) cell analysis for the
diagnosis and management of patients with interstitial lung disease (ILD) has been a subject …

Background: The diagnosis of sarcoidosis is not standardized but is based on three major
criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous …

Background Patients with acute respiratory distress syndrome (ARDS) have a deficiency of
surfactant. Surfactant replacement improves physiologic function in such patients, and …

Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …

Past research suggests that environmental factors may be associated with sarcoidosis risk.
We conducted a case control study to test a priori hypotheses that environmental and …

Rationale: Evidence suggests that tumor necrosis factor (TNF)-α plays an important role in
the pathophysiology of sarcoidosis. Objectives: To assess the efficacy of infliximab in …